Yousif Capital Management LLC Sells 1,411 Shares of CME Group Inc. (NASDAQ:CME)

Yousif Capital Management LLC decreased its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 2.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 50,544 shares of the financial services provider’s stock after selling 1,411 shares during the quarter. Yousif Capital Management LLC’s holdings in CME Group were worth $11,738,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Truvestments Capital LLC acquired a new stake in CME Group in the 3rd quarter valued at approximately $26,000. SJS Investment Consulting Inc. boosted its position in shares of CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 97 shares during the period. Dunhill Financial LLC grew its stake in shares of CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 81 shares during the last quarter. Financial Life Planners bought a new position in CME Group during the fourth quarter worth $32,000. Finally, Fortitude Family Office LLC raised its stake in CME Group by 120.3% during the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 83 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

NASDAQ CME opened at $241.64 on Thursday. The firm has a market cap of $87.08 billion, a price-to-earnings ratio of 25.41, a PEG ratio of 5.37 and a beta of 0.57. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $249.02. The company has a 50 day moving average of $235.11 and a 200-day moving average of $223.36.

CME Group announced that its Board of Directors has authorized a share buyback plan on Thursday, December 5th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the financial services provider to purchase up to 3.4% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board believes its stock is undervalued.

CME Group Increases Dividend

The firm also recently disclosed a dividend, which was paid on Thursday, January 16th. Shareholders of record on Friday, December 27th were given a $5.80 dividend. This is an increase from CME Group’s previous dividend of $2.50. The ex-dividend date was Friday, December 27th. CME Group’s payout ratio is presently 48.37%.

Analyst Ratings Changes

Several research firms recently weighed in on CME. Citigroup cut shares of CME Group from a “buy” rating to a “neutral” rating and reduced their target price for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Oppenheimer lifted their price objective on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Barclays upped their target price on CME Group from $231.00 to $257.00 and gave the company an “equal weight” rating in a research note on Monday, December 9th. Royal Bank of Canada reiterated a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research note on Monday, January 6th. Finally, Morgan Stanley increased their price objective on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, CME Group currently has a consensus rating of “Hold” and a consensus target price of $229.27.

Read Our Latest Stock Analysis on CME

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.